Galapagos Genomics NV And BASF AG Extend Research Collaborations

February 2, 2006 |

1 min read

Drug discovery company, Galapagos NV said it has extended three research collaborations into 2006 with BASF Aktiengesellschaft in Ludwigshafen, Germany with the total contract value of the extensions exceeding 700,000 eur.

Alliances Europe

MORE ON THIS TOPIC

Vaccines

Pfizer CEO Blasts HHS’ Anti-Vaccine Policies as Revenue Outlook Dims

December 16, 2025

·

3 min read

·

Annalee Armstrong

Contemporary art collage. Purple hand holding fan of dollar bills against bright yellow background. stock photo

Venture capital

Ambros Launches With $125M To Bring Italian Non-Opioid Pain Drug to America

December 16, 2025

·

1 min read

·

Annalee Armstrong

Illustration of businessman running back around

Autoimmune disease

Sanofi Taps Dren Again in up to $1.7B Autoimmune Partnership

December 15, 2025

·

1 min read

·

Annalee Armstrong

Rheumatoid arthritis (RA) commonly causes inflammation in the hands, leading to pain, swelling, and stiffness in the joints, particularly the small joints of the fingers and wrists. This inflammation results from the immune system attacking the body's own joint tissues, causing the synovium (lining of the joint) to become inflamed and release chemicals that damage nearby tissues.

Mergers & acquisitions

Sobi Makes $1.5B Gout Play With Arthrosi Acquisition

December 15, 2025

·

2 min read

·

Tristan Manalac